Pathologic Fracture: What It Is, Why It Happens, and How to Manage It

What is Pathologic Fracture?

A pathologic fracture is a break in a bone that occurs at a site weakened by an underlying disease, rather than from a typical high‑impact trauma such as a fall from height or a car accident. The bone may fracture from a minor bump, a simple twist, or even normal daily activities like walking or lifting a light object. Because the structural integrity of the bone has already been compromised, relatively little force is needed to cause a break.

Pathologic fractures are most often seen in older adults, but they can occur at any age when specific disease processes erode bone strength. Prompt recognition is crucial because the fracture frequently signals an active, sometimes serious, systemic condition that needs treatment beyond simply setting the bone.

Common Causes

Several medical conditions can weaken bone and predispose it to a pathologic fracture. The most frequent causes include:

• Osteoporosis – age‑related loss of bone density, the leading cause of fragility fractures in post‑menopausal women and older men.
• Metastatic cancer – cancers that spread to bone (e.g., breast, prostate, lung, kidney, thyroid) create lytic or blastic lesions that destabilize the skeleton.
• Primary bone tumors – such as osteosarcoma, Ewing sarcoma, or multiple myeloma, which directly destroy bone tissue.
• Paget’s disease of bone – abnormal remodeling that produces enlarged, weakened bone.
• Osteomalacia / Rickets – defective bone mineralization due to vitamin D deficiency or phosphate disorders.
• Chronic steroid use – long‑term glucocorticoid therapy reduces bone formation and increases resorption.
• Rheumatologic conditions – such as rheumatoid arthritis or systemic lupus erythematosus, especially when combined with glucocorticoid therapy.
• Infection (osteomyelitis) – bacterial or fungal infection can create a bone cavity (sequestrum) that fractures easily.
• Hyperparathyroidism – excess parathyroid hormone leads to bone resorption and weakened cortical bone.
• Genetic bone disorders – e.g., osteogenesis imperfecta or hypophosphatasia, which produce brittle bones from birth.

While these are the most common, any disease that interferes with bone formation, remodeling, or mineralization can potentially lead to a pathologic fracture.

Associated Symptoms

The fracture itself often generates a characteristic set of signs, but many patients also experience symptoms related to the underlying disease:

• Sudden, localized bone pain that may have been present before the fracture.
• Swelling, warmth, or bruising over the affected area.
• Deformity or inability to bear weight on the limb.
• Loss of function – e.g., difficulty walking, raising the arm, or using the hand.
• Systemic clues such as unexplained weight loss, night sweats, or fever (suggesting malignancy or infection).
• History of chronic back pain or spinal tenderness (common with vertebral compression fractures).
• Visible bone lesions on prior imaging studies (if the patient has known cancer or metabolic disease).

When to See a Doctor

Because a pathologic fracture may be the first manifestation of a serious condition, early medical evaluation is essential. Seek care promptly if you notice any of the following:

• Sudden bone pain after minimal or no trauma.
• Persistent pain that worsens with activity or at night.
• Visible deformity, swelling, or inability to move the affected limb.
• History of cancer, osteoporosis, or chronic steroid use combined with new bone pain.
• Fever, chills, or redness over a bone, which may indicate infection.
• Neurologic symptoms (numbness, tingling, weakness) after a suspected fracture, especially in the spine.

If you fall and experience any of these red‑flag signs, call your health‑care provider or go to an urgent care center. For spinal fractures with neurologic changes or severe pain, seek emergency care immediately.

Diagnosis

Diagnosing a pathologic fracture involves confirming the break and uncovering the underlying cause. The typical work‑up follows these steps:

1. Clinical Evaluation

• Detailed history (trauma level, prior cancer, medications, bone health risk factors).
• Physical examination focused on the site of pain, neurovascular status, and signs of systemic disease.

2. Imaging Studies

• X‑ray – first‑line for visualizing a fracture line, displacement, and obvious lytic or blastic lesions.
• CT scan – provides cross‑sectional detail, useful for complex anatomic areas (spine, pelvis) and surgical planning.
• MRI – best for evaluating bone marrow infiltration, soft‑tissue involvement, and spinal cord compression.
• Bone scan (technetium‑99m) – highlights areas of increased metabolic activity; helpful when multiple lesions are suspected.
• PET/CT – often used in cancer patients to stage metastatic disease and differentiate benign from malignant lesions.

3. Laboratory Tests

• Complete blood count (CBC) – may reveal anemia or infection.
• Serum calcium, phosphate, and alkaline phosphatase – abnormal in metabolic bone disease.
• 25‑hydroxy vitamin D level – assesses deficiency.
• Serum protein electrophoresis (SPEP) and urine light chain analysis – screen for multiple myeloma.
• Tumor markers (e.g., PSA, CA‑15‑3) if a known primary cancer is present.

4. Tissue Diagnosis

If imaging suggests a primary bone tumor or metastatic lesion, a biopsy (core needle or open) is performed to obtain histology. This guides definitive oncologic therapy.

5. Assessment of Bone Health

Dual‑energy X‑ray absorptiometry (DEXA) may be ordered to quantify osteoporosis severity, especially when the fracture occurs in a typical osteoporotic site such as the hip or vertebrae.

Treatment Options

Management is two‑pronged: stabilize the fracture and treat the underlying disease.

1. Acute Fracture Management

• Immobilization – splints, casts, or braces to protect the fracture during healing.
• Surgical fixation – intramedullary nails, plates, screws, or vertebral augmentation (vertebroplasty/kyphoplasty) when the bone is too weak for simple casting.
• External fixation – used for complex or contaminated wounds, often in oncologic cases.
• Pain control – acetaminophen, NSAIDs (if no contraindication), or short courses of opioids while the underlying cause is addressed.

2. Addressing the Underlying Cause

• Osteoporosis – bisphosphonates (alendronate, zoledronic acid), denosumab, or anabolic agents (teriparatide) plus calcium (1,200 mg/day) and vitamin D3 (800–1,000 IU/day).
• Metastatic disease – systemic therapy (hormone therapy, chemotherapy, targeted agents, immunotherapy) plus possible radiation to the specific bone site.
• Primary bone tumors – surgical resection, chemotherapy, and/or radiotherapy based on tumor type and stage.
• Paget’s disease – bisphosphonates (zoledronic acid) to normalize remodeling.
• Osteomalacia/Rickets – high‑dose vitamin D (e.g., 50,000 IU weekly) and correction of phosphorus deficiency.
• Infection (osteomyelitis) – long‑term antibiotics, possible surgical debridement, and immobilization.
• Hyperparathyroidism – surgical removal of overactive parathyroid tissue; medical management with calcimimetics if surgery isn’t possible.

3. Rehabilitation & Home Care

• Physical therapy to restore range of motion, strength, and gait once the fracture is stable.
• Occupational therapy for activities of daily living, especially after upper‑extremity fractures.
• Home safety modifications – grab bars, non‑slip mats, adequate lighting to reduce future falls.
• Nutrition – adequate protein (1.0–1.2 g/kg body weight) and nutrients supporting bone healing.

Prevention Tips

While not all pathologic fractures can be avoided, many risk factors are modifiable:

• Maintain bone density – regular weight‑bearing exercise (walking, dancing, resistance training) and adequate calcium/vitamin D intake.
• Screen for osteoporosis – DEXA scan at age 65 (or earlier with risk factors) and treat if T‑score ≤ ‑2.5.
• Limit long‑term glucocorticoids – use the lowest effective dose, and add bone‑protective agents if chronic use is required.
• Control chronic diseases – keep diabetes, thyroid disorders, and hyperparathyroidism well‑managed.
• Quit smoking & limit alcohol – both accelerate bone loss.
• Monitor known cancers – regular imaging and oncologic follow‑up to detect bone metastases early.
• Fall‑prevention strategies – exercise programs focused on balance (Tai chi, yoga), proper footwear, and home hazard reduction.
• Vaccinations – influenza and pneumococcal vaccines reduce infection risk, which can secondarily weaken bone.

Emergency Warning Signs

• Sudden, severe pain with inability to move the affected limb or bear weight.
• Visible deformity, such as an obvious “bend” or “step-off” in a bone.
• Signs of spinal cord compression – numbness, tingling, weakness, or loss of bladder/bowel control.
• Rapid swelling, redness, or warmth suggesting an acute infection (osteomyelitis).
• Unexplained fever (> 38 °C or 100.4 °F) accompanying bone pain.
• Bright red or pulsatile bleeding from the fracture site.
• Persistent, worsening pain despite rest and over‑the‑counter pain medication.

These symptoms require immediate medical attention—call 911 or go to the nearest emergency department.

Key Take‑aways

• A pathologic fracture is a break in a bone weakened by disease, not by a high‑energy injury.
• Common causes include osteoporosis, metastatic cancer, primary bone tumors, Paget’s disease, and chronic steroid use.
• Typical symptoms are sudden localized pain, swelling, and loss of function; systemic signs may point to the underlying illness.
• Prompt evaluation with X‑ray, advanced imaging, labs, and sometimes biopsy is essential.
• Treatment combines fracture stabilization with disease‑specific therapy and rehabilitation.
• Preventive measures—bone health optimization, fall safety, and management of chronic conditions—reduce risk.
• Seek emergency care for severe pain, deformity, neurologic changes, fever, or rapid swelling.

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, Journal of Bone & Joint Surgery, The Lancet Oncology.